BMY (Bristol Myers Squibb) Stock Analysis - Hedge Fund Holdings

Bristol Myers Squibb (BMY) is a publicly traded Healthcare sector company. As of May 20, 2026, BMY trades at $58.52 with a market cap of $117.03B and a P/E ratio of 16.83. BMY moved +0.20% today. Year to date, BMY is +9.07%; over the trailing twelve months it is +23.49%. Its 52-week range spans $42.52 to $63.33. Analyst consensus is buy with an average price target of $64.29. Rallies surfaces BMY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns BMY stock?

Hedge funds tracked by Rallies that own BMY include Panagora Asset, Pinebridge Investments, Orbimed Advisors, Berkshire Asset, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Bristol Myers Squibb.

BMY Key Metrics

Key financial metrics for BMY
MetricValue
Price$58.52
Market Cap$117.03B
P/E Ratio16.83
EPS$3.47
Dividend Yield0.63%
52-Week High$63.33
52-Week Low$42.52
Volume5.21M
Avg Volume0
Revenue (TTM)$48.19B
Net Income$7.05B
Gross Margin71.08%

Top Hedge Funds Holding BMY

  • Panagora Asset holds 3.72M shares of BMY, changed +12.74% as of Mar 31, 2026.
  • Pinebridge Investments holds 968.83K shares of BMY, changed -20.02% as of Sep 30, 2025.
  • Orbimed Advisors holds 925.00K shares of BMY, changed +19.35% as of Mar 31, 2026.
  • Berkshire Asset holds 593.86K shares of BMY, changed +1.93% as of Mar 31, 2026.
  • Bridgewater Associates holds 241.69K shares of BMY, changed -40.89% as of Mar 31, 2026.

Latest BMY News

Recent BMY Insider Trades

  • Elkins David V sold 25.52K (~$1.57M) on Apr 1, 2026.
  • Elkins David V sold 4.48K (~$278.05K) on Apr 1, 2026.

BMY Analyst Consensus

18 analysts cover BMY: 0 strong buy, 6 buy, 12 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $64.29.

Common questions about BMY

Who owns BMY stock?
Hedge funds tracked by Rallies that own BMY include Panagora Asset, Pinebridge Investments, Orbimed Advisors, Berkshire Asset, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Bristol Myers Squibb.
Does Rallies show 13F holders for BMY?
Yes. Rallies tracks hedge fund and 13F ownership data for BMY, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BMY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BMY. It does not provide personalized investment advice.
BMY

Bristol Myers Squibb